CNO (Life insurers) Stock Valuation & Fair Value Mixed on our tests
CNO (Life insurers) trades at a current P/E of 11.4, about 6% above its historical normal valuation, with a forward growth estimate of 8.9% and a PEG of 1.29. Analysts' one-year estimates have been hit 27% of the time. Priced at its historical normal P/E of 10.8 on the same blended earnings, the 2026-10-23 close of $53.66 corresponds to about $50.80 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is CNO overvalued?
At a current P/E of 11.4 versus its historical normal P/E of 10.8, CNO trades about 6% above its typical valuation, with a PEG of 1.29 on 8.9% forward growth. tickerseer currently rates it mixed on our tests.
What is CNO's fair value and PEG?
CNO trades at a current P/E of 11.4 against a historical normal P/E of 10.8, a PEG of 1.29, and a forward growth estimate of 8.9%. Priced at its historical normal P/E of 10.8 on the same blended earnings, the 2026-10-23 close of $53.66 corresponds to about $50.80 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of CNO changed?
tickerseer's rating has been mixed on our tests since 2026-10-24.
Industry: Life insurers. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.